Product Design & Development in Montréal, QC
Find accurate info on the best product design & development services in Montréal. Get reviews and contact details for each business, including phone number, address, opening hours, promotions and other information.
Showing results: 1 - 20 out of 28
Showing results: 1 - 20 out of 28
Results from the 'Product Design & Development' category in Montréal
Closed now
5333 Casgrain Ave, Montréal, H2T 1X3
(438) 498-5895
Punctuate Design is an industrial and product design studio based in Montreal.? We help purpose driven companies design physical and digital products that have a positive impact on our planet. 
Closed now
3410, Thimens blvd., Montréal, H4R 1V6
(514) 998-3713
Research and product development 
Closed now
781 William St Suite 303, Montréal, H3C 1N8
(514) 591-3491
Black Duck Agency is a forward-thinking marketing firm, specializing in creative solutions across industries. We excel in strategy, fostering lasting brand-consumer connections. With a talented team and integrated approach, we drive impactful results, guided by innovation and excellence. Unleash your brand's potential! 
Closed now
800, De La Gauchetière W., Suite 6900, Montréal, H5A 1K6
(514) 228-7011
Engineering Service, College & University, Research and product development 
Closed now
55 Rue de Louvain O #460-06, Montréal, H2N 1A4
Closed now
460 Saint-Catherine Street West, Montréal, H3B 1A6
+1 514-874-3224
Webisoft specializes in full-service blockchain, web and software development solutions for startups and established enterprises. We build blockchain and SaaS apps and websites that are fast, secure, responsive, and clean.We work mainly on Solana, Ethereum and the Cosmos based chain.We also offer integration, marketing, and maintenance services to complement our development services as a turnkey solution. 
Webisoft is a competent software company with a team that listens to clients' problems and delivers solutions tailored to their needs. The team is precise, intelligent, human, and geeky, creating a unique work environment. Customers have had positive experiences working with the company for extended periods. 
Closed now
2550 Chemin Bates, Suite 404, Montréal, H3S 1A7
514 343 5003
Laboratory Equipment Repair Service, Laboratoires-Equipement, Laboratoires, Fournitures et services industriels, ile de montréal centre, laboratory equipment repair, fournitures & services, Research and product development, service 
Closed now
6300 Ave du Parc # 420, Montréal, H2V 4H8
(514) 461-3010
Engineering Service, Research and product development 
Closed now
3800 Saint-Patrick St #200, Montréal, H4E 1A4
(802) 879-7002
Research and product development 
9615 Avenue Papineau, Suite 105, Montréal, H2B 1Z6
(514) 702-7702
Research and product development 
9880 Rue Clark #101, Montréal, H3L 2R3
(514) 971-1396
Research and product development 
5450 Chemin de la Côte-des-Neiges #522, Montréal, H3T 1Y6
(514) 282-4523
Research and product development 
2001 McGill College Ave #500, Montréal, H3A 1G1
(514) 398-7203
1000 de La Gauchetière Street West, Montréal, H3B 5H4
(514) 533-0373
Mimetogen Pharmaceuticals is a clinical stage biotechnology company focused on developing the use of peptidomimetics as a novel approach to treating ophthalmic diseases with high unmet medical needs. The underlying technology was developed at McGill University and the Lady Davis Institute for Medical Research in Montreal. MIM-D3, Mimetogen’s lead compound is currently being evaluated in a multi-center Phase 3 clinical study in the United States for the treatment of dry eye syndrome. In addition, the Company has developed novel therapeutic approaches for other ophthalmology indications including glaucoma and other degenerative diseases of the retina such as retinitis pigmentosa. To successfully advance the development of its novel class of neurotrophin mimetics, Mimetogen management team has assembled a world-class group of advisors comprised of renowned experts and clinical development collaborators in the field of ophthalmology, all dedicated to the development of new therapeutic options for eye diseases that to date have only limited or no treatment or cure.